DE60111540T2 - Tetrazolylphenyl-acetamide als glukokinaseaktivatoren - Google Patents

Tetrazolylphenyl-acetamide als glukokinaseaktivatoren Download PDF

Info

Publication number
DE60111540T2
DE60111540T2 DE60111540T DE60111540T DE60111540T2 DE 60111540 T2 DE60111540 T2 DE 60111540T2 DE 60111540 T DE60111540 T DE 60111540T DE 60111540 T DE60111540 T DE 60111540T DE 60111540 T2 DE60111540 T2 DE 60111540T2
Authority
DE
Germany
Prior art keywords
methyl
phenyl
mmol
reaction mixture
tetrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111540T
Other languages
German (de)
English (en)
Other versions
DE60111540D1 (de
Inventor
Achyutharao Livingston Essex County SIDDURI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60111540D1 publication Critical patent/DE60111540D1/de
Application granted granted Critical
Publication of DE60111540T2 publication Critical patent/DE60111540T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60111540T 2000-08-15 2001-08-09 Tetrazolylphenyl-acetamide als glukokinaseaktivatoren Expired - Lifetime DE60111540T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22549400P 2000-08-15 2000-08-15
US225494P 2000-08-15
PCT/EP2001/009207 WO2002014312A1 (en) 2000-08-15 2001-08-09 Tetrazolyl-phenyl acetamide glucokinase activators

Publications (2)

Publication Number Publication Date
DE60111540D1 DE60111540D1 (de) 2005-07-21
DE60111540T2 true DE60111540T2 (de) 2006-03-16

Family

ID=22845106

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111540T Expired - Lifetime DE60111540T2 (de) 2000-08-15 2001-08-09 Tetrazolylphenyl-acetamide als glukokinaseaktivatoren

Country Status (20)

Country Link
US (3) US6369232B1 (https=)
EP (1) EP1311504B1 (https=)
JP (1) JP3961948B2 (https=)
KR (1) KR100518061B1 (https=)
CN (1) CN1209362C (https=)
AR (1) AR031718A1 (https=)
AT (1) ATE297921T1 (https=)
AU (2) AU8399801A (https=)
BR (1) BR0113312A (https=)
CA (1) CA2419416C (https=)
DE (1) DE60111540T2 (https=)
DK (1) DK1311504T3 (https=)
ES (1) ES2243541T3 (https=)
MX (1) MXPA03001275A (https=)
PA (1) PA8525201A1 (https=)
PE (1) PE20020386A1 (https=)
PT (1) PT1311504E (https=)
UY (1) UY26885A1 (https=)
WO (1) WO2002014312A1 (https=)
ZA (1) ZA200300904B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
BR0314864A (pt) * 2002-10-03 2005-08-02 Novartis Ag Compostos orgânicos
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
PE20040801A1 (es) 2002-12-12 2004-11-25 Hoffmann La Roche Derivados de pirazina y piridina 5-sustituidos como activadores de glucoquinasa
AU2003294376A1 (en) * 2003-01-06 2004-08-10 Eli Lilly And Company Heteroaryl compounds
WO2004072066A1 (en) * 2003-02-11 2004-08-26 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
AU2005229415B2 (en) 2004-04-02 2009-05-14 Novartis Ag Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
US7750020B2 (en) 2004-04-02 2010-07-06 Novartis Ag Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes
CA2614746C (en) 2005-07-09 2011-05-10 Astrazeneca Ab Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
WO2007007886A1 (en) * 2005-07-11 2007-01-18 Mitsubishi Tanabe Pharma Corporation An oxime derivative and preparations thereof
CA2621227A1 (en) 2005-08-31 2007-03-08 Astellas Pharma Inc. Thiazole derivative
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
JP2009509988A (ja) 2005-09-29 2009-03-12 サノフィ−アベンティス フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
JP2009514835A (ja) * 2005-11-03 2009-04-09 プロシディオン・リミテッド トリシクロ置換型アミド
JP2009515997A (ja) * 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド グルコキナーゼ活性剤
BRPI0619980A2 (pt) * 2005-12-15 2014-10-14 Nihon Nohyaku Co Ltd Derivados de ftalamida e de anilina, inseticida agrícola ou hortícula, e, método de uso do mesmo
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP2049518B1 (en) * 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
US7910747B2 (en) * 2006-07-06 2011-03-22 Bristol-Myers Squibb Company Phosphonate and phosphinate pyrazolylamide glucokinase activators
US7902248B2 (en) 2006-12-14 2011-03-08 Hoffmann-La Roche Inc. Oxime glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
TW200831081A (en) * 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
WO2008084872A1 (ja) 2007-01-10 2008-07-17 Mitsubishi Tanabe Pharma Corporation ヒドラゾン誘導体
MX2009009525A (es) 2007-03-07 2009-09-16 Kyorin Seiyaku Kk Activador de glucocinasa.
US8173645B2 (en) * 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
US8501955B2 (en) * 2007-10-08 2013-08-06 Advinus Therapeutics Private Limited Acetamide derivatives as glucokinase activators, their process and medicinal application
PE20091313A1 (es) * 2008-01-15 2009-09-03 Lilly Co Eli (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina
AU2009205070A1 (en) * 2008-01-18 2009-07-23 Astellas Pharma Inc. Phenyl acetamide derivative
SI2275414T1 (sl) 2008-04-28 2015-10-30 Kyorin Pharmaceutical Co., Ltd., Ciklopentilakrilamidni derivat
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
GB8909574D0 (en) 1989-04-26 1989-06-14 Ici Plc Chemical process
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
US5461049A (en) * 1994-05-27 1995-10-24 Warner-Lambert Company Amide tetrazole ACAT inhibitors
KR20000070568A (ko) * 1997-01-28 2000-11-25 폴락 돈나 엘. 당뇨병 및 비만 치료를 위한 β3 효능제로서의 티아졸 벤젠설폰아미드
SI1169312T1 (en) * 1999-03-29 2005-02-28 F. Hoffmann-La Roche Ag Glucokinase activators

Also Published As

Publication number Publication date
PE20020386A1 (es) 2002-05-13
CN1466584A (zh) 2004-01-07
MXPA03001275A (es) 2003-06-30
ZA200300904B (en) 2004-04-30
BR0113312A (pt) 2003-07-01
US6441180B1 (en) 2002-08-27
US20020035266A1 (en) 2002-03-21
KR100518061B1 (ko) 2005-09-28
PA8525201A1 (es) 2002-07-30
CN1209362C (zh) 2005-07-06
AU2001283998B2 (en) 2005-10-20
AU8399801A (en) 2002-02-25
CA2419416A1 (en) 2002-02-21
US20020035267A1 (en) 2002-03-21
DE60111540D1 (de) 2005-07-21
CA2419416C (en) 2009-10-13
EP1311504B1 (en) 2005-06-15
EP1311504A1 (en) 2003-05-21
PT1311504E (pt) 2005-10-31
JP2004506632A (ja) 2004-03-04
UY26885A1 (es) 2002-02-28
JP3961948B2 (ja) 2007-08-22
US20020065275A1 (en) 2002-05-30
WO2002014312A1 (en) 2002-02-21
ES2243541T3 (es) 2005-12-01
US6369232B1 (en) 2002-04-09
DK1311504T3 (da) 2005-10-17
ATE297921T1 (de) 2005-07-15
US6388088B1 (en) 2002-05-14
AR031718A1 (es) 2003-10-01
KR20030022408A (ko) 2003-03-15

Similar Documents

Publication Publication Date Title
DE60111540T2 (de) Tetrazolylphenyl-acetamide als glukokinaseaktivatoren
DE60022903T2 (de) Olefinische trans-glukokinase-aktivatoren
DE60108108T2 (de) Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren
DE60106599T2 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
DE60117059T2 (de) Kondensierte heteroaromatische glucokinaseaktivatoren
DE60316709T2 (de) Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren
DE60111534T2 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
EP1283830B1 (en) Para-amine substituted phenylamide glucokinase activators
AU2001283998A1 (en) Tetrazolyl-phenyl acetamide glucokinase activators
DE60309856T2 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
DE60315886T2 (de) Substituierte pyrazin- oder pyridin-derivate als glukokinase-aktivatoren
DE60014610T2 (de) Glukokinase aktivatoren
AU2001287600A1 (en) Alpha-acyl and Alpha-heteroatom-substituted Benzene Acetamide Glucokinase Activators
US20010051731A1 (en) Para-amine substituted phenylamide glucokinase activators

Legal Events

Date Code Title Description
8364 No opposition during term of opposition